Leuprolide Acetate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 3.75 mg, 7.5 mg, 11.25 mg, 22.5 mg
Reference Brands: Lupron (USA), Eligard (USA/EU), Leupro (India)
Category:
Oncology Cancer Care
Leuprolide is a GnRH agonist used in oncology and hormone-related conditions. It helps reduce sex hormone levels to manage prostate cancer, breast cancer, endometriosis, uterine fibroids, and precocious puberty.
Leuprolide Acetate is available in Injection
and strengths such as 3.75 mg, 7.5 mg, 11.25 mg, 22.5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Leuprolide Acetate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Leuprolide Acetate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Leuprolide is a synthetic gonadotropin-releasing hormone (GnRH) agonist used to manage and treat conditions related to sex hormones. It is commonly prescribed for prostate cancer, endometriosis, uterine fibroids, and precocious puberty. By acting on the pituitary gland, Leuprolide initially stimulates and then suppresses the production of sex hormones such as testosterone and estrogen, helping to slow or control the progression of hormone-sensitive conditions.
Leuprolide is available in injectable and depot formulations, allowing for short-term or long-term hormone suppression depending on the clinical need. It plays a critical role in oncology, gynecology, and pediatric endocrinology, offering a therapeutic option for patients requiring hormone modulation. The medication is carefully monitored for side effects, contraindications, and hormone levels, making interprofessional coordination essential in patient management. Its ability to effectively reduce hormone-driven disease activity has made Leuprolide a cornerstone treatment in both cancer therapy and reproductive health management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing